PROK
Ticker
ProKidney Corp.
PROK · Healthcare · ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney d…ProKidney Corp. (PROK), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 2 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 20 and filed Aug 20. The most active filer was Control Empresarial de Capitales S.A. de C.V. with 3 filings.
Add to watchlistFilings, ttm
2
0 buys · 2 sells
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$2.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 20
Filed Aug 20
ADViAverage daily dollar volume
$1.7M
market data
Share price · 12M
$1.74 (-36.5%)
Adjusted for splits and dividends.
Volume by month
Buys $1.4M
Sells $3.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
CV
Control Empresarial de Capitales S.A. de C.V.
10% owner
3 filings
BPRecent filings
Brian JG PereiraSALE
Director
$952K675,235 sh across 3 lots
Exec Aug 18
Filed Aug 20 · 5:00 PM ET Brian JG PereiraSALE Director $1.8M
729,567 sh across 3 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET Darin J. WeberSALE Chief Regulatory Officer $313K
103,480 sh × $3.02
Exec Jul 8 2025
Filed Jul 9 2025 · 5:30 PM ET Control Empresarial de Capitales S.A. de C.V.PURCHASE 10% owner $275K
387,393 sh × $0.71
Exec Apr 22 2025
Filed Apr 24 2025 · 5:30 PM ET Control Empresarial de Capitales S.A. de C.V.PURCHASE 10% owner $523K
736,105 sh across 2 lots
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET Control Empresarial de Capitales S.A. de C.V.PURCHASE 10% owner $630K
1,032,218 sh × $0.61
Exec Apr 10 2025
Filed Apr 14 2025 · 5:30 PM ET